Departments Provide Submission Grace Period (Ending Jan. 31, 2023) and Good Faith Reporting Relief for CAA-21 Prescription Drug Cost Reporting Rules | Practical Law
The Departments of Labor (DOL), Health and Human Services (HHS), and Treasury (collectively, Departments) have issued FAQ guidance addressing the pharmacy benefit and prescription drug cost reporting requirements added by the Consolidated Appropriations Act, 2021 (CAA-21). The FAQs include good faith compliance relief regarding the prescription drug reporting requirements, a limited submission grace period (until January 31, 2023), and several clarifications concerning the reporting rules.